Swiss Tech Funding Surpasses €1.1B in H1 2026

Switzerland's technology sector demonstrated robust capital attraction in the first half of 2026, with over €1.1 billion flowing into innovative companies. This significant influx was notably concentrated, as the top ten funding rounds accounted for approximately two-thirds of the total capital raised, underscoring a trend towards substantial investments in a select few high-potential ventures. The semiconductor industry emerged as a primary beneficiary, drawing in roughly €281 million, closely followed by the energy sector with €223 million, and healthtech securing €220 million. This focus highlights investor confidence in deep technology and critical infrastructure solutions.

Among the leading fundraisers, semiconductor innovator Kandou secured a substantial $225 million. This funding is earmarked for scaling production of its advanced AI connectivity chips, deepening engagement with hyperscale data center clients, and advancing its next-generation chip and intellectual property development. The company's focus on addressing data movement bottlenecks is particularly relevant as artificial intelligence systems continue to demand higher processing and communication speeds, a market segment projected for significant expansion.

In the energy domain, Terralayr raised €192 million to bolster its grid-scale battery storage portfolio, particularly within Germany, and to further expand its LAYR platform. This platform is designed to aggregate and virtualize battery capacity, offering on-demand energy flexibility to utilities and market participants. The investment reflects a growing emphasis on grid modernization and the integration of renewable energy sources, where energy storage plays a pivotal role in ensuring stability and reliability.

The healthtech sector also saw significant backing, with medical device firm CeQur raising $100 million in a Series E round. This capital infusion is intended to broaden its commercial reach, enhance field sales operations, and support the ongoing development of its insulin delivery solutions for diabetes management. The company's wearable patch technology offers a convenient alternative to traditional injection methods, addressing a critical need in chronic disease care.

Beyond these headline figures, other sectors like cleantech also attracted considerable investment. While fintech, software, and other technology sub-sectors saw a higher volume of transactions, these were generally smaller in scale. This distribution indicates a market that balances broad early-stage activity with significant capital deployment into sectors requiring substantial R&D and infrastructure investment, such as advanced materials, energy storage, and specialized medical devices.

The funding mix comprised a variety of stages, with Series A rounds proving particularly attractive, bolstered by several large-scale deals. Later-stage financing, including Series C and E rounds, also contributed significantly. While seed and pre-seed investments were more dispersed across a larger number of smaller rounds, the overall trend points to a maturing Swiss tech ecosystem capable of supporting companies from inception through to significant growth phases. This dynamic environment is crucial for fostering innovation and driving economic growth within the region.